Vascular calcification in skin and subcutaneous tissue in patients with chronic and end-stage kidney disease

Irene Ruderman1,2, Tim D Hewitson3,4, Edward R Smith3,4

  • 1Department of Nephrology, The Royal Melbourne Hospital, 300 Grattan St, Parkville, Victoria, 3050, Australia. irene_ruderman@hotmail.com.

BMC Nephrology
|July 18, 2020
PubMed

Insights

Vascular calcification (VC) affects skin and subcutaneous tissues in 38% of advanced chronic kidney disease (CKD) patients. This study identified VC in multiple body sites, highlighting a previously under-recognized complication in CKD patients not experiencing calciphylaxis.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Dermatology

Background:

  • Vascular calcification (VC) is common in large vessels of chronic kidney disease (CKD) patients, particularly end-stage kidney disease (ESKD) on dialysis.
  • Medial calcification in CKD contributes to arterial stiffness, increasing cardiovascular risks.
  • Skin and subcutaneous calcification in CKD, outside of calciphylaxis, is understudied.

Purpose of the Study:

  • To investigate the prevalence and characteristics of dermal and subcutaneous VC in CKD patients.
  • To compare skin calcification in CKD patients with a control cohort.
  • To explore associations with bone and mineral metabolism and specific gene expression.

Main Methods:

  • An observational study evaluated incisional skin tissue samples from three anatomical sites in CKD patients and controls.
  • Von Kossa staining assessed calcification, and RT-PCR analyzed gene expression (TNAP, RUNX2) in a subset of samples.
  • Patients with varying stages of CKD, including ESKD, were included.

Main Results:

  • Vascular calcification (VC) was found in 15 of 45 samples (33%), including 13 from 34 CKD/ESKD patients and 2 from 11 controls.
  • VC occurred in dermal and subcutaneous tissues across neck, abdomen, and arm samples, with two histological types identified.
  • No significant differences in serum parathyroid hormone, phosphate, or calcium were observed between patients with or without VC; TNAP or RUNX2 expression was not elevated.

Conclusions:

  • Dermal and subcutaneous calcification is a novel finding in 38% of advanced CKD/ESKD patients undergoing surgery, independent of calciphylaxis.
  • VC was identified in multiple anatomical locations in the skin and subcutaneous tissue.
  • The study did not find correlations between VC and standard bone/mineral markers or specific gene upregulation in this cohort.
Abstract

Related Concept Videos

Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
434
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
251
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
437
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
204
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
266